期刊文献+

2型糖尿病患者非酒精性脂肪肝与颈动脉粥样硬化关系的研究 被引量:1

Relationship between NAFLD and Carotid Artery Atherosclerosis in Type 2 Diabetes
下载PDF
导出
摘要 目的以颈动脉内膜中层厚度(IMT)为主要研究参数,探讨新诊断2型糖尿病(T2DM)患者非酒精性脂肪肝病(NAFLD)与颈动脉粥样硬化之间的关系。方法观察对象分为三组:对照组:39例健康对照者;糖尿病无NAFLD组:33例单纯性新诊断2型糖尿病者;糖尿病NAFLD组:38例新诊断2型糖尿病合并NAFLD者,比较三组IMT,并将IMT与HOMA-IR、血脂等指标进行相关性分析。结果与对照组比较,新诊断T2DM患者存在颈动脉内膜增厚([1.12±0.11)mmvs(0.81±0.12)mm,P<0.05)],当伴有NAFLD时其颈动脉内膜增厚更加明显及颈动脉粥样斑块形成增多([1.35±0.13)mmvs(1.12±0.11)mm,P<0.05)]。在T2DM患者中,IMT与HOMA-IR呈显著正相关(r=0.485,P<0.05)。结论新诊断T2DM患者存在颈动脉内膜增厚,当伴有NAFLD时,其颈动脉内膜更加增厚且颈动脉斑块形成增多。 Objective To investigate the relationship between non-alcoholic fatty liver disease and carotid artery atherosclerosis in newly diagnosed type 2 diabetes.Methods We divided 110 cases into three groups by blood glucose level and ultrasonic examination results:control group (39 cases with normal blood glucose level),T2DM without NAFLD group (33 cases newly diagnosed as type 2 diabetes without NAFLD and T2DM with NAFLD group (38 cases newly diagnosed as type 2 diabetes with NAFLD).Carotid artery intima-media thicknes (IMT) was determined by colorful Doppler ultrasonography.Results Compared with the control group,the T2DM with or without NAFLD groups showed higher mean IMT(1.12±0.11)mm vs(0.81±0.12)mm(P 0.05).The IMT in the T2DM with NAFLD group was higher than that in the T2DM without NAFLD group and increased carotid artery atheromatous plaque(1.35±0.13)mm vs(1.12±0.11)mm(P0.05).The IMT was positively associated with HOMA-IR(r=0.485,P0.05).Conclusion Newly diagnosed type 2 diabetes shows increased carotid artery intima-media thickness,and the IMT in newly diagnosed type 2 diabetes with NAFLD is more severe than that in T2DM without NAFLD.
出处 《中国现代医生》 2010年第22期38-40,共3页 China Modern Doctor
关键词 2型糖尿病 非酒精性脂肪肝病 颈动脉内膜中层厚度 颈动脉粥样硬化 Type 2 diabetes Non-alcoholic fatty liver disease Carotid artery intima-media thickness Atherosclerosis
  • 相关文献

参考文献15

  • 1Stamler J,Vaccaro O,Neaton J,et al. For the multiple Risk Factor Intervention Trial Research Group Diabetes other risk factor,and 12-years cardiovascularmortality formen screened in the Multiple Risk Factor Intervention Trial[J].Diabetes Care, 1993,16:434-444.
  • 2Pi P,Tremoli E,Poll A,et al. Intima media thickness of the arterial wall:a direct measurement with ultrasound imaging[J]. Circulation, 1986,74:1399-1406.
  • 3Pujia A,Gnasso A,Irace C,et al. Common carotid arterial wall thickness in NDD subjects[J]. Diabetes Care,1994:17:1330-1336.
  • 4Bonora E,Kiechl S,Oberhollenzer F,et al. Impaired Glucose tolerance type 2 diabetes mellitus and carotid Atheroscleros is prospective results from the Bruneck Study[J]. Diabetologia 2000,43:156-164.
  • 5杜锦,汪寅章,智光,杨波,潘长玉.颈动脉内-中膜厚度与糖代谢异常的关系及影响因素[J].中国全科医学,2006,9(16):1328-1331. 被引量:24
  • 6Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 7Targher G,Bertolini L,Poli F,et al. Relationsp between carotid artery wall thickness and liver histology in subjects with Nonalcoholic fatty liver disease[J]. Diab care,2006,29:1325-330.
  • 8Pacifico L, Cantisani V,Ricci P,et al. Nonalcoholic fatty liver disease and carotid atherosclerosis in children[J]. Pediatr Res,2008,63 (4) : 423-427.
  • 9Sattar N, Scherbakova O, Ford I, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors,metabolic syndrome,and C-reactive protein in the West of Scotland Coronary Prevention Study[J]. Diabetes,2004,53: 2855-2860.
  • 10Gupte P, Amarapurkar D, Agal S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus[J]. J Gastroenterol Hepatol, 2004,19: 854-858.

二级参考文献43

  • 1詹晓蓉,肖彧君,母义明,李明,陆祖谦,陆菊明,潘长玉.花生四烯酸对饱和脂肪酸的血管内皮细胞毒性的保护作用[J].中华内分泌代谢杂志,2004,20(5):453-456. 被引量:9
  • 2胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 3Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 4Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 5Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 6Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 7Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 8Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 9Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 10Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.

共引文献1549

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部